Vanquish Healthcare
Holdings
The global population is increasing at a rapid rate and we are living longer, though not necessarily healthier, lives. This results in a far greater demand on the healthcare sector. Pharmaceutical companies, delivery providers and insurers are natural beneficiaries of this, but some of the largest gains may be found in the fields of bio tech and robotics.
Vanquish Healthcare seeks to take full advantage of this though a carefully constructed portfolio of stocks providing exposure to both established industry stalwarts and companies on the cutting edge of research and development.
Vertex Pharmasuiticals
A leader in genetic therapies and cystic fibrosis treatments, Vertex has a strong pipeline for rare diseases and genetic disorders, positioning it for significant long-term growth driven by innovative therapies and expanding market needs.
Intuative Surgical
Pioneering robot-assisted surgery with its da Vinci Surgical System, Intuitive Surgical benefits from the growing adoption of minimally invasive surgeries, positioning the company for strong long-term growth in the evolving healthcare landscape.
Medpace
A leading pharmaceutical distributor and clinical research organization, Medpace is positioned for strong growth driven by increasing demand for clinical trials and biotech research, making it a strong contender in the global healthcare market.
TransMedics Group
A leader in organ transplant technologies, particularly for heart, liver, and lung transplants, TransMedics has significant growth potential as the global demand for transplants rises, bolstering its position in the healthcare market.
United Healthcare
As the largest health insurer in the US, United Health Group is expanding its focus on value-based care and integrated services, poised to capitalize on the growing healthcare market and evolving patient care models.
HCA Healthcare
A leader in US hospital operations and surgical centers, HCA Healthcare benefits from increasing demand for healthcare services, expanding its footprint with strategic acquisitions and strengthening its position in the healthcare provider sector.
Thermo Fisher Scientific
A global leader in scientific instruments and biotech services, Thermo Fisher is well-positioned to capitalize on the expanding genomics and biopharma industries, driving growth in critical areas such as diagnostics and lab services.
Pfizer
With strong performance in vaccines and oncology, Pfizer continues to grow through its immuno-oncology therapies and biologics, offering long-term growth potential as demand for innovative treatments remains strong globally.
Merck & Co
Merck leads the oncology market with its revolutionary cancer treatment, Keytruda, while also investing in gene therapy and biologics, positioning the company for long-term success in the rapidly evolving biotech and pharmaceutical markets.
Abbott Labortories
A diversified leader across diagnostics, medical devices, and nutrition, Abbott is a key player in diabetes care and cardiovascular devices, positioned for strong growth with expanding demand for its healthcare solutions worldwide.
McKesson Corporation
A leader in pharmaceutical distribution and healthcare logistics, McKesson is well positioned to benefit from the growing healthcare demand, driving growth in its core pharmaceutical distribution and supply chain management businesses.
Cardinal Health
A major US healthcare provider with a significant presence in hospitals and outpatient centers, Tenet Healthcare is poised for growth as healthcare demand increases in a post-pandemic environment, expanding its services across key regions.